Rehabilitation Interventions in Adults with Amyotrophic Lateral Sclerosis: A Review

Rehabilitation in Adults with ALS

Authors

  • Maryam Behroozinia Department of Physical Medicine and Rehabilitation, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  • Saeid Khosrawi Department of Physical Medicine and Rehabilitation, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

DOI:

https://doi.org/10.31661/gmj.vi.3708

Keywords:

Amyotrophic Lateral Sclerosis; Rehabilitation; Exercise Therapy

Abstract

Amyotrophic Lateral Sclerosis (ALS) is the most common and rapidly devastating neurodegenerative disease, which causes impairment of motor neurons in the upper and lower limbs, as well as in the bulbar muscles among adults. This leads to progressive weakness of voluntary muscles. The median survival after the emergence of initial symptoms is typically three years. During this period, due to the worsening of general well-being and independence, patients and their caregivers experience significant emotional stress. Furthermore, there is currently no definitive treatment for ALS. Consequently, patients face various challenges associated with motor impairment, including mobility disturbances, respiratory dysfunction, speech difficulties, and limitations in activities of daily living. Therefore, rehabilitation plays a vital role as a component of multidisciplinary care for managing these issues and reducing the impact of the disease on patients and their families. It is considered the optimal choice for alleviating the discomfort of ALS patients until a curative treatment is discovered.
This narrative review aims to provide an overview of different aspects of rehabilitation, including physical therapy, occupational therapy, speech therapy, and respiratory strategies focused on enhancing independence, functional abilities, and overall quality of life while minimizing disabilities and complications in patients coping with this debilitating condition.

References

Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162-72.

https://doi.org/10.1056/NEJMra1603471

PMid:28700839

Cunha-Oliveira T, Montezinho L, Mendes C, Firuzi O, Saso L, Oliveira PJ, et al. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxid Med Cell Longev. 2020;2020:5021694.

https://doi.org/10.1155/2020/5021694

PMid:33274002 PMCid:PMC7683149

van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084-98.

https://doi.org/10.1016/S0140-6736(17)31287-4

PMid:28552366

Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett. 2019;710:132933.

https://doi.org/10.1016/j.neulet.2017.06.052

PMid:28669745

Cruz MP. Edaravone (Radicava): A Novel Neuroprotective Agent for the Treatment of Amyotrophic Lateral Sclerosis. P T. 2018;43(1):25-8.

Soriani MH, Desnuelle C. Care management in amyotrophic lateral sclerosis. Rev Neurol (Paris). 2017;173(5):288-99.

https://doi.org/10.1016/j.neurol.2017.03.031

PMid:28461024

Obrador E, Salvador R, López-Blanch R, Jihad-Jebbar A, Vallés SL, Estrela JM. Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis. Antioxidants (Basel). 2020;9(9):901.

https://doi.org/10.3390/antiox9090901

PMid:32971909 PMCid:PMC7555310

Tard C, Defebvre L, Moreau C, Devos D, Danel-Brunaud V. Clinical features of amyotrophic lateral sclerosis and their prognostic value. Rev Neurol (Paris). 2017;173(5):263-72.

https://doi.org/10.1016/j.neurol.2017.03.029

PMid:28477850

Gamskjaer T, Werlauff U, Handberg C. Investigating job satisfaction in palliative rehabilitation: Reflections and perspectives of health professionals working with amyotrophic lateral sclerosis. J Eval Clin Pract. 2022;28(1):108-19.

https://doi.org/10.1111/jep.13599

PMid:34269500

Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10(5-6):310-23.

https://doi.org/10.3109/17482960802566824

PMid:19922118 PMCid:PMC3515205

Silva JPR, Júnior JBS, Dos Santos EL, de Carvalho FO, de França Costa IMP, de Mendonça DMF. Quality of life and functional independence in amyotrophic lateral sclerosis: A systematic review. Neurosci Biobehav Rev. 2020;111:1-11.

https://doi.org/10.1016/j.neubiorev.2019.12.032

PMid:31917162

Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-9.

https://doi.org/10.1080/146608200300079536

PMid:11464847

De Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119(3):497-503.

https://doi.org/10.1016/j.clinph.2007.09.143

PMid:18164242

Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82(6):623-7.

https://doi.org/10.1136/jnnp.2010.224501

PMid:21047878

Battaglia G, Bruno V. Metabotropic glutamate receptor involvement in the pathophysiology of amyotrophic lateral sclerosis: new potential drug targets for therapeutic applications. Curr Opin Pharmacol. 2018;38:65-71.

https://doi.org/10.1016/j.coph.2018.02.007

PMid:29529498

Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, et al. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015;6:171.

https://doi.org/10.4103/2152-7806.169561

PMid:26629397 PMCid:PMC4653353

Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015:181-93.

https://doi.org/10.2147/CLEP.S37505

PMid:25709501 PMCid:PMC4334292

Pupillo E, Poloni M, Bianchi E, Giussani G, Logroscino G, Zoccolella S, et al. Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(1-2):118-25.

https://doi.org/10.1080/21678421.2017.1386687

PMid:29063790

Logan R, Dubel-Haag J, Schcolnicov N, Miller SJ. Novel genetic signatures associated with sporadic amyotrophic lateral sclerosis. Front Genet. 2022;13:851496.

https://doi.org/10.3389/fgene.2022.851496

PMid:35401706 PMCid:PMC8986983

Chia R, Chio A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17(1):94-102.

https://doi.org/10.1016/S1474-4422(17)30401-5

PMid:29154141

Duffy JR, Peach RK, Strand EA. Progressive apraxia of speech as a sign of motor neuron disease. AJA. 2007;16(3):198-208.

https://doi.org/10.1044/1058-0360(2007/025)

PMid:17666546

Kuwabara S, Sonoo M, Komori T, Shimizu T, Hirashima F, Inaba A, et al. Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificity. Muscle Nerve. 2008;37(4):426-30.

https://doi.org/10.1002/mus.20949

PMid:18236469

Riad SM, Hathout H, Huang JC. High T2 signal in primary lateral sclerosis supports the topographic distribution of fibers in the corpus callosum: assessing disease in the primary motor segment. AJNR Am J Neuroradiol. 2011;32(4):E61-4.

https://doi.org/10.3174/ajnr.A2067

PMid:20299433 PMCid:PMC7965866

Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918-29.

https://doi.org/10.1111/ene.14393

PMid:32526057 PMCid:PMC7540334

Ajroud-Driss S, Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS). Biochim Biophys Acta. 2015;1852(4):679-84.

https://doi.org/10.1016/j.bbadis.2014.08.010

PMid:25193032

Ferguson TA, Elman LB. Clinical presentation and diagnosis of amyotrophic lateral sclerosis. NeuroRehabilitation. 2007;22(6):409-16.

https://doi.org/10.3233/NRE-2007-22602

Leigh PN, Abrahams S, Al-Chalabi A, Ampong MA, Goldstein LH, Johnson J, et al. The management of motor neurone disease. J Neurol Neurosurg Psychiatry. 2003;74 Suppl 4(Suppl 4):iv32-iv47.

Rabinstein AA, Wijdicks EF. Warning signs of imminent respiratory failure in neurological patients. Semin Neurol. 2003;23(1):97-104.

https://doi.org/10.1055/s-2003-40757

PMid:12870111

Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942-55.

https://doi.org/10.1016/S0140-6736(10)61156-7

PMid:21296405

Parvizi J, Anderson SW, Martin CO, Damasio H, Damasio AR. Pathological laughter and crying: a link to the cerebellum. Brain. 2001;124(Pt 9):1708-19.

https://doi.org/10.1093/brain/124.9.1708

PMid:11522574

Garuti G, Rao F, Ribuffo V, Sansone VA. Sialorrhea in patients with ALS: current treatment options. Degener Neurol Neuromuscul Dis. 2019;9:19-26.

https://doi.org/10.2147/DNND.S168353

PMid:31118868 PMCid:PMC6498144

Danel-Brunaud V, Touzet L, Chevalier L, Moreau C, Devos D, Vandoolaeghe S, et al. Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: a review. Rev Neurol (Paris). 2017;173(5):300-7.

https://doi.org/10.1016/j.neurol.2017.03.032

PMid:28479121

Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76(14):1263-9.

https://doi.org/10.1212/WNL.0b013e318214359f

PMid:21464431

Dorst J, Ludolph AC, Huebers A. Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis. Ther Adv Neurol Disord. 2018;11:1756285617734734.

https://doi.org/10.1177/1756285617734734

PMid:29399045 PMCid:PMC5784546

Ilieva H, Vullaganti M, Kwan J. Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis. Bmj. 2023;383:e075037.

https://doi.org/10.1136/bmj-2023-075037

PMid:37890889 PMCid:PMC10603569

Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev. 2012;2012(3):CD001447.

https://doi.org/10.1002/14651858.CD001447.pub3

PMid:22419278

Deng Y, Xu Z, Xu B, Tian Y, Xin X, Deng X, et al. The protective effect of riluzole on manganese caused disruption of glutamate-glutamine cycle in rats. Brain Res. 2009;1289:106-17.

https://doi.org/10.1016/j.brainres.2009.07.012

PMid:19615351

Bensimon G, Lacomblez L, Delumeau JC, Bejuit R, Truffinet P, Meininger V, et al. A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis. J Neurol. 2002;249(5):609-15.

https://doi.org/10.1007/s004150200071

PMid:12021952

Tzeplaeff L, Wilfling S, Requardt MV, Herdick M. Current State and Future Directions in the Therapy of ALS. Cells. 2023;12(11):1523.

https://doi.org/10.3390/cells12111523

PMid:37296644 PMCid:PMC10252394

Schultz J. Disease-modifying treatment of amyotrophic lateral sclerosis. Am J Manag Care. 2018;24(15 Suppl):S327-S35.

Lejman J, Panuciak K, Nowicka E, Mastalerczyk A, Wojciechowska K, Lejman M. Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives. Int J Mol Sci. 2023;24(2):1130.

https://doi.org/10.3390/ijms24021130

PMid:36674643 PMCid:PMC9860634

de Carvalho M, Nogueira A, Pinto A, Miguens J, Sales Luis ML. Reflex sympathetic dystrophy associated with amyotrophic lateral sclerosis. J Neurol Sci. 1999;169(1-2):80-3.

https://doi.org/10.1016/S0022-510X(99)00220-8

PMid:10540012

Assouline A, Levy A, Abdelnour-Mallet M, Gonzalez-Bermejo J, Lenglet T, Le Forestier N, et al. Radiation therapy for hypersalivation: a prospective study in 50 amyotrophic lateral sclerosis patients. Int J Radiat Oncol Biol Phys. 2014;88(3):589-95.

https://doi.org/10.1016/j.ijrobp.2013.11.230

PMid:24411632

Moore DH, Miller RG. Improving efficiency of ALS clinical trials using lead-in designs. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 57-60.

https://doi.org/10.1080/17434470410019997

PMid:15512875

White LJ, Dressendorfer RH. Exercise and multiple sclerosis. Sports Med. 2004;34(15):1077-100.

https://doi.org/10.2165/00007256-200434150-00005

PMid:15575796

Majmudar S, Wu J, Paganoni S. Rehabilitation in amyotrophic lateral sclerosis: why it matters. Muscle Nerve. 2014;50(1):4-13.

https://doi.org/10.1002/mus.24202

PMid:24510737 PMCid:PMC4433000

Karam CY, Paganoni S, Joyce N, Carter GT, Bedlack R. Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based Review. Am J Hosp Palliat Care. 2016;33(1):84-92.

https://doi.org/10.1177/1049909114548719

PMid:25202033 PMCid:PMC4439378

Medicine ACoS. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc. 1998;30:975-91.

https://doi.org/10.1249/00005768-199806000-00032

Tsitkanou S, Della Gatta P, Foletta V, Russell A. The role of exercise as a non-pharmacological therapeutic approach for amyotrophic lateral sclerosis: beneficial or detrimental? Front Neurol. 2019;10:783.

https://doi.org/10.3389/fneur.2019.00783

PMid:31379732 PMCid:PMC6652799

Clawson LL, Cudkowicz M, Krivickas L, Brooks BR, Sanjak M, Allred P, et al. A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(3-4):250-8.

https://doi.org/10.1080/21678421.2017.1404108

PMid:29191052

Kato N, Hashida G, Konaka K. Effect of muscle strengthening exercise and time since onset in patients with amyotrophic lateral sclerosis: A 2-patient case series study. Medicine (Baltimore). 2018;97(25):e11145.

https://doi.org/10.1097/MD.0000000000011145

PMid:29924018 PMCid:PMC6024467

Psalidas CP, Kottaras A, Lytras D, Iakovidis P, Leptourgos G, Moutaftsis K. The role of therapeutic exercise as a means of intervention for the treatment of amyotrophic lateral sclerosis. Int J Adv Community Med. 2021;4(2):29-31.

https://doi.org/10.33545/comed.2021.v4.i2a.193

Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI. Physical activity, trauma, and ALS: a case-control study. Acta Neurol Scand. 1996;94(1):45-50.

https://doi.org/10.1111/j.1600-0404.1996.tb00038.x

PMid:8874593

Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52(7):1311-23.

https://doi.org/10.1212/WNL.52.7.1311

PMid:10227612

Harwood CA, McDermott CJ, Shaw PJ. Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler. 2009;10(4):191-204.

https://doi.org/10.1080/17482960802549739

PMid:19263258

Harwood CA, Westgate K, Gunstone S, Brage S, Wareham NJ, McDermott CJ, et al. Long-term physical activity: an exogenous risk factor for sporadic amyotrophic lateral sclerosis? Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(5-6):377-84.

https://doi.org/10.3109/21678421.2016.1154575

PMid:26998882 PMCid:PMC4950417

Krivickas LS. Rehabilitation of Amyotrophic Lateral Sclerosis. Motor Neuron Disease. 2008:31.

https://doi.org/10.1016/B978-1-4160-4007-1.50127-9

Gruis KL, Lechtzin N. Respiratory therapies for amyotrophic lateral sclerosis: a primer. Muscle Nerve. 2012;46(3):313-31.

https://doi.org/10.1002/mus.23282

PMid:22907221

Miller RG, Brooks BR, Swain-Eng RJ, Basner RC, Carter GT, Casey P, et al. Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of Neurology. Neurology. 2013;81(24):2136-40.

https://doi.org/10.1212/01.wnl.0000437305.37850.f9

PMid:24271651 PMCid:PMC3863352

Niedermeyer S, Murn M, Choi PJ. Respiratory Failure in Amyotrophic Lateral Sclerosis. Chest. 2019;155(2):401-8.

https://doi.org/10.1016/j.chest.2018.06.035

PMid:29990478

Ferreira GD, Costa AC, Plentz RD, Coronel CC, Sbruzzi G. Respiratory training improved ventilatory function and respiratory muscle strength in patients with multiple sclerosis and lateral amyotrophic sclerosis: systematic review and meta-analysis. Physiotherapy. 2016;102(3):221-8.

https://doi.org/10.1016/j.physio.2016.01.002

PMid:27026167

Plowman EK, Tabor-Gray L, Rosado KM, Vasilopoulos T, Robison R, Chapin JL, et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham-controlled trial. Muscle Nerve. 2019;59(1):40-6.

https://doi.org/10.1002/mus.26292

PMid:29981250

Rafiq MK, Bradburn M, Proctor AR, Billings CG, Bianchi S, McDermott CJ, et al. A preliminary randomized trial of the mechanical insufflator-exsufflator versus breath-stacking technique in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):448-55.

https://doi.org/10.3109/21678421.2015.1051992

PMid:26140500

Tzelepis GE, Vega DL, Cohen ME, Fulambarker AM, Patel KK, McCool FD. Pressure-flow specificity of inspiratory muscle training. J Appl Physiol (1985). 1994;77(2):795-801.

https://doi.org/10.1152/jappl.1994.77.2.795

PMid:8002530

Tzelepis GE, Kadas V, McCool FD. Inspiratory muscle adaptations following pressure or flow training in humans. Eur J Appl Physiol Occup Physiol. 1999;79(6):467-71.

https://doi.org/10.1007/s004210050538

PMid:10344453

Silva IS, Pedrosa R, Azevedo IG, Forbes AM, Fregonezi GA, Dourado Junior ME, et al. Respiratory muscle training in children and adults with neuromuscular disease. Cochrane Database Syst Rev. 2019;9(9):CD011711.

https://doi.org/10.1002/14651858.CD011711.pub2

PMid:31487757

Cabrita B, Dias S, Fernandes AL, Correia S, Ferreira J, Simao P. Inspiratory muscle training in neuromuscular patients: Assessing the benefits of a novel protocol. J Back Musculoskelet Rehabil. 2021;34(4):537-43.

https://doi.org/10.3233/BMR-200141

PMid:33523039

Vicente-Campos D, Sanchez-Jorge S, Chicharro JL, Becerro-de Bengoa-Vallejo R, Rodriguez-Sanz D, Garcia AR, et al. POWERbreathe((R)) Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis. J Clin Med. 2022;11(22):6655.

https://doi.org/10.3390/jcm11226655

PMid:36431132 PMCid:PMC9698064

Dubbioso R, Spisto M, Hausdorff JM, Aceto G, Iuzzolino VV, Senerchia G, et al. Cognitive impairment is associated with gait variability and fall risk in amyotrophic lateral sclerosis. Eur J Neurol. 2023;30(10):3056-67.

https://doi.org/10.1111/ene.15936

PMid:37335396

Lange DJ, Murphy PL, Maxfield RA, Skarvala A-M, Riedel G. Management of patients with amyotrophic lateral sclerosis. J Neurol Rehabil. 1994;8(2):75-82.

https://doi.org/10.1177/136140969400800204

Creemers H, Beelen A, Grupstra H, Nollet F, van den Berg LH. The provision of assistive devices and home adaptations to patients with ALS in the Netherlands: patients' perspectives. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(5-6):420-5.

https://doi.org/10.3109/21678421.2014.920031

PMid:24899120

Boostani R, Olfati N, Shamshiri H, Salimi Z, Fatehi F, Hedjazi SA, et al. Iranian clinical practice guideline for amyotrophic lateral sclerosis. Front Neurol. 2023;14:1154579.

https://doi.org/10.3389/fneur.2023.1154579

PMid:37333000 PMCid:PMC10272856

Lindenberger E, Meier DE. What Special Considerations Are Needed for Individuals With Amyotrophic Lateral Sclerosis, Multiple Sclerosis, or Parkinson Disease? Evidence-Based Practice in Palliative Medicine. 2013:317-29.

https://doi.org/10.1016/B978-1-4377-3796-7.00056-2

Lou JS, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60(1):122-3.

https://doi.org/10.1212/01.WNL.0000042781.22278.0A

PMid:12525733

Fateh HR, Askary-Kachoosangy R, Shirzad N, Akbarzadeh-Baghban A, Fatehi F. The effect of energy conservation strategies on fatigue, function, and quality of life in adults with motor neuron disease: Randomized controlled trial. Curr J Neurol. 2022;21(2):83-90.

https://doi.org/10.18502/cjn.v21i2.10491

PMid:38011426 PMCid:PMC9860213

Kos D, Duportail M, Meirte J, Meeus M, D'Hooghe M B, Nagels G, et al. The effectiveness of a self-management occupational therapy intervention on activity performance in individuals with multiple sclerosis-related fatigue: a randomized-controlled trial. Int J Rehabil Res. 2016;39(3):255-62.

https://doi.org/10.1097/MRR.0000000000000178

PMid:27182847

Vanage SM, Gilbertson KK, Mathiowetz V. Effects of an energy conservation course on fatigue impact for persons with progressive multiple sclerosis. Am J Occup Ther. 2003;57(3):315-23.

https://doi.org/10.5014/ajot.57.3.315

PMid:12785670

Mathiowetz VG, Matuska KM, Finlayson ML, Luo P, Chen HY. One-year follow-up to a randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Int J Rehabil Res. 2007;30(4):305-13.

https://doi.org/10.1097/MRR.0b013e3282f14434

PMid:17975450

Matuska K, Mathiowetz V, Finlayson M. Use and perceived effectiveness of energy conservation strategies for managing multiple sclerosis fatigue. Am J Occup Ther. 2007;61(1):62-9.

https://doi.org/10.5014/ajot.61.1.62

PMid:17302106

Lewis M, Rushanan S. The role of physical therapy and occupational therapy in the treatment of amyotrophic lateral sclerosis. NeuroRehabilitation. 2007;22(6):451-61.

https://doi.org/10.3233/NRE-2007-22608

PMid:18198431

Ball L, Beukelman D, Bardach L. AAC intervention for ALS Paul H. Brookes Baltimore. 2007; 43(6):841-78.

Yorkston KM, Beukelman DR, Strand EA, Hakel M. Management of motor speech disorders in children and adults. Pro-ed Austin: TX; 1999.

Beukelman DR, Garrett KL, Yorkston KM. Augmentative communication strategies for adults with acute or chronic medical conditions. Brookes: Pub; 2007.

Tomik B, Guiloff RJ. Dysarthria in amyotrophic lateral sclerosis: A review. Amyotroph Lateral Scler. 2010;11(1-2):4-15.

https://doi.org/10.3109/17482960802379004

PMid:20184513

Pugliese R, Sala R, Regondi S, Beltrami B, Lunetta C. Emerging technologies for management of patients with amyotrophic lateral sclerosis: from telehealth to assistive robotics and neural interfaces. J Neurol. 2022;269(6):2910-21.

https://doi.org/10.1007/s00415-022-10971-w

PMid:35059816 PMCid:PMC8776511

Murphy J. Communication strategies of people with ALS and their partners. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(2):121-6.

https://doi.org/10.1080/14660820410020411

PMid:15204014

Beukelman D, Fager S, Nordness A. Communication support for people with ALS. Neurol Res Int. 2011;2011:714693.

https://doi.org/10.1155/2011/714693

PMid:21603029 PMCid:PMC3096454

Gelinas D, Miller R. A treatable disease: a guide to the management of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis London: Martin Dunitz. 2000:405-22.

Bongioanni P. Communication impairment in. ALS patients assessment and treatment: Citeseer; 2012.

https://doi.org/10.5772/30426

PMCid:PMC3463670

Linse K, Aust E, Joos M, Hermann A. Communication matters-pitfalls and promise of hightech communication devices in palliative care of severely physically disabled patients with amyotrophic lateral sclerosis. Front Neurol. 2018;9:603.

https://doi.org/10.3389/fneur.2018.00603

PMid:30100896 PMCid:PMC6072854

Clerc M, Mattout J, Maby E, Devlaminck D, Papadopoulo T, Guy V, et al. Verbal communication through brain computer interfaces. Interspeech-14th Annual Conference of the International Speech Communication Association-2013. 2013; :00842851.

Guy V, Soriani M-H, Bruno M, Papadopoulo T, Desnuelle C, Clerc M. Brain computer interface with the P300 speller: Usability for disabled people with amyotrophic lateral sclerosis. Ann Phys Rehabil Med. 2018;61(1):5-11.

https://doi.org/10.1016/j.rehab.2017.09.004

PMid:29024794

Edughele HO, Zhang Y, Muhammad-Sukki F, Vien Q-T, Morris-Cafiero H, Agyeman MO. Eye-tracking assistive technologies for individuals with amyotrophic lateral sclerosis. IEEE Access. 2022;10:41952-72.

https://doi.org/10.1109/ACCESS.2022.3164075

Calvo A, Chiò A, Castellina E, Corno F, Farinetti L, Ghiglione P, et al. Eye tracking impact on quality-of-life of ALS patients Computers Helping People with Special Needs: 11th International Conference, ICCHP 2008, Linz, Austria, July 9-11, 2008 Proceedings 11. Springer. 2008; :70-78.

Cipresso P, Meriggi P, Carelli L, Solca F, Meazzi D, Poletti B, et al. The combined use of Brain Computer Interface and Eye-Tracking technology for cognitive assessment in Amyotrophic Lateral Sclerosis 2011 5th International conference on pervasive computing technologies for healthcare (PervasiveHealth) and workshops. IEEE. 2011; : 320-324.

https://doi.org/10.4108/icst.pervasivehealth.2011.246018

Ball LJ, Nordness AS, Fager SK, Kersch K, Mohr B, Pattee GL, et al. Eye gaze access of AAC technology for people with amyotrophic lateral sclerosis. J Med Speech-Lang Pathol. 2010;18(3):11.

Paganoni S, Karam C, Joyce N, Bedlack R, Carter GT. Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. NeuroRehabilitation. 2015;37(1):53-68.

https://doi.org/10.3233/NRE-151240

PMid:26409693 PMCid:PMC5223769

Tabor L, Gaziano J, Watts S, Robison R, Plowman EK. Defining Swallowing-Related Quality of Life Profiles in Individuals with Amyotrophic Lateral Sclerosis. Dysphagia. 2016;31(3):376-82.

https://doi.org/10.1007/s00455-015-9686-2

PMid:26837611 PMCid:PMC4871719

Printza A, Boziki M, Triaridis S, Kiousi V, Arnaoutoglou M, Constantinidis J, et al. Tongue strength, dysphagia questionnaire, pharyngeal secretions and FEES findings in dysphagia management in amyotrophic lateral sclerosis. Auris Nasus Larynx. 2021;48(4):672-82.

https://doi.org/10.1016/j.anl.2020.10.007

PMid:33109427

Muscaritoli M, Kushta I, Molfino A, Inghilleri M, Sabatelli M, Rossi Fanelli F. Nutritional and metabolic support in patients with amyotrophic lateral sclerosis. Nutrition. 2012;28(10):959-66.

https://doi.org/10.1016/j.nut.2012.01.011

PMid:22677356

Palovcak M, Mancinelli JM, Elman LB, McCluskey L. Diagnostic and therapeutic methods in the management of dysphagia in the ALS population: issues in efficacy for the out-patient setting. NeuroRehabilitation. 2007;22(6):417-23.

https://doi.org/10.3233/NRE-2007-22603

PMid:18198426

Dorst J, Cypionka J, Ludolph AC. High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(7-8):533-6.

https://doi.org/10.3109/21678421.2013.823999

PMid:23944684

Greenwood DI. Nutrition management of amyotrophic lateral sclerosis. Nutr Clin Pract. 2013;28(3):392-9.

https://doi.org/10.1177/0884533613476554

PMid:23466470

Verschueren A, Monnier A, Attarian S, Lardillier D, Pouget J. Enteral and parenteral nutrition in the later stages of ALS: an observational study. Amyotroph Lateral Scler. 2009;10(1):42-6.

https://doi.org/10.1080/17482960802267480

PMid:18615338

Scott AG, Austin HE. Nasogastric feeding in the management of severe dysphagia in motor neurone disease. Palliat Med. 1994;8(1):45-9.

https://doi.org/10.1177/026921639400800108

PMid:8180740

Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218-26.

https://doi.org/10.1212/WNL.0b013e3181bc0141

PMid:19822872 PMCid:PMC2764727

Park JH, Kang SW. Percutaneous radiologic gastrostomy in patients with amyotrophic lateral sclerosis on noninvasive ventilation. Arch Phys Med Rehabil. 2009;90(6):1026-9.

https://doi.org/10.1016/j.apmr.2008.12.006

PMid:19480880

Stavroulakis T, Baird WO, Baxter SK, Walsh T, Shaw PJ, McDermott CJ. Factors influencing decision-making in relation to timing of gastrostomy insertion in patients with motor neurone disease. BMJ Support Palliat Care. 2014;4(1):57-63.

https://doi.org/10.1136/bmjspcare-2013-000497

PMid:24644772

Shoesmith C. Palliative care principles in ALS. Handb Clin Neurol. 2023;191:139-55.

https://doi.org/10.1016/B978-0-12-824535-4.00007-0

PMid:36599506

Diagnosis ETFo, Sclerosis: MoAL, Andersen PM, Abrahams S, Borasio GD, de Carvalho M, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360-75.

https://doi.org/10.1111/j.1468-1331.2011.03501.x

PMid:21914052

Hess DR. Noninvasive ventilation in neuromuscular disease: equipment and application. Respir Care. 2006;51(8):896-911.

Bourke S, Bullock R, Williams T, Shaw P, Gibson G. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology. 2003;61(2):171-7.

https://doi.org/10.1212/01.WNL.0000076182.13137.38

PMid:12874394

Mustfa N, Walsh E, Bryant V, Lyall R, Addington-Hall J, Goldstein L, et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology. 2006;66(8):1211-7.

https://doi.org/10.1212/01.wnl.0000208957.88534.11

PMid:16636239

Georges M, Morelot-Panzini C, Similowski T, Gonzalez-Bermejo J. Noninvasive ventilation reduces energy expenditure in amyotrophic lateral sclerosis. BMC Pulm Med. 2014;14(1):17.

https://doi.org/10.1186/1471-2466-14-17

PMid:24507664 PMCid:PMC3922008

Goldberg A. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation--a. Chest. 1999;116(2):521.

https://doi.org/10.1378/chest.116.2.521

PMid:10453883

Vrijsen B, Testelmans D, Belge C, Vanpee G, Van Damme P, Buyse B. Patient-ventilator asynchrony, leaks and sleep in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(5-6):343-50.

https://doi.org/10.3109/21678421.2016.1170149

PMid:27077786

Antonelli M, Conti G, Pelosi P, Gregoretti C, Pennisi MA, Costa R, et al. New treatment of acute hypoxemic respiratory failure: noninvasive pressure support ventilation delivered by helmet--a pilot controlled trial. Crit Care Med. 2002;30(3):602-8.

https://doi.org/10.1097/00003246-200203000-00019

PMid:11990923

Fiorentino G, Annunziata A, Gaeta AM, Lanza M, Esquinas A. Continuous noninvasive ventilation for respiratory failure in patients with amyotrophic lateral sclerosis: current perspectives. Degener Neurol Neuromuscul Dis. 2018;8:55-61.

https://doi.org/10.2147/DNND.S170771

PMid:30233272 PMCid:PMC6130289

Everett EA, Pedowitz E, Maiser S, Cohen J, Besbris J, Mehta AK, et al. Top ten tips palliative care clinicians should know about amyotrophic lateral sclerosis. J Palliat Med. 2020;23(6):842-7.

https://doi.org/10.1089/jpm.2020.0046

PMid:32101493

Kim HS, Woo H, Choi SJ, Baek JG, Ryu JS, Shin HI, et al. Factors associated with adherence to noninvasive positive pressure ventilation in amyotrophic lateral sclerosis. PLoS One. 2024;19(5):e0302515.

https://doi.org/10.1371/journal.pone.0302515

PMid:38748695 PMCid:PMC11095767

Melo J, Homma A, Iturriaga E, Frierson L, Amato A, Anzueto A, et al. Pulmonary evaluation and prevalence of non-invasive ventilation in patients with amyotrophic lateral sclerosis: a multicenter survey and proposal of a pulmonary protocol. J Neurol Sci.. 1999;169(1-2):114-7.

https://doi.org/10.1016/S0022-510X(99)00228-2

PMid:10540018

Pinto S, De Carvalho M. Is a four-hour use of non-invasive ventilation enough to define compliance? Amyotroph Lateral Scler . 2010;11(1-2):250-2.

https://doi.org/10.3109/17482960903214480

PMid:19722113

Hadjikoutis S, Wiles C, Eccles R. Cough in motor neuron disease: a review of mechanisms. Qjm. 1999;92(9):487-94.

https://doi.org/10.1093/qjmed/92.9.487

PMid:10627867

McHenry KL. Airway Clearance Strategies and Secretion Management in Amyotrophic Lateral Sclerosis. Respir Care. 2024;69(2):227-37.

https://doi.org/10.4187/respcare.11215

PMid:37816542 PMCid:PMC10898456

Jones U, Enright S, Busse M. Management of respiratory problems in people with neurodegenerative conditions: a narrative review. Physiotherapy. 2012;98(1):1-12.

https://doi.org/10.1016/j.physio.2011.03.002

PMid:22265380

Lange D, Lechtzin N, Davey C, David W, Heiman-Patterson T, Gelinas D, et al. High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial. Neurology. 2006;67(6):991-7.

https://doi.org/10.1212/01.wnl.0000237439.78935.46

PMid:17000967

Ambrosino N, Carpene N, Gherardi M. Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J. 2009;34(2):444-51.

https://doi.org/10.1183/09031936.00182208

PMid:19648521

Sancho J, Servera E, Díaz J, Marín J. Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest. 2004;125(4):1400-5.

https://doi.org/10.1378/chest.125.4.1400

PMid:15078752

Funo K, Negishi Y, Akamine C, Takeuchi R, Uzawa Y. Setting Mechanical Insufflation-Exsufflation (MI-E) Pressures for Amyotrophic Lateral Sclerosis (ALS) Patients to Improve Atelectasis and Reduce Risk of Pneumothorax: A Case Report. Cureus. 2022;14(6):e25786.

https://doi.org/10.7759/cureus.25786

PMid:35812619 PMCid:PMC9270190

Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines An evidence-based review with good practice points EALSC Working Group. Amyotroph Lateral Scler. 2007;8(4):195-213.

https://doi.org/10.1080/17482960701262376

PMid:17653917

Morris LL, Whitmer A, McIntosh E. Tracheostomy care and complications in the intensive care unit. Crit Care Nurse. 2013;33(5):18-30.

https://doi.org/10.4037/ccn2013518

PMid:24085825

Spataro R, Bono V, Marchese S, La Bella V. Tracheostomy mechanical ventilation in patients with amyotrophic lateral sclerosis: clinical features and survival analysis. J Neurol Sci. 2012;323(1-2):66-70.

https://doi.org/10.1016/j.jns.2012.08.011

PMid:22989611

Magelssen M, Holmoy T, Horn MA, Fondenaes OA, Dybwik K, Forde R. Ethical challenges in tracheostomy-assisted ventilation in amyotrophic lateral sclerosis. J Neurol. 2018;265(11):2730-6.

https://doi.org/10.1007/s00415-018-9054-x

PMid:30218178

Hayashi N, Atsuta N, Yokoi D, Nakamura R, Nakatochi M, Katsuno M, et al. Prognosis of amyotrophic lateral sclerosis patients undergoing tracheostomy invasive ventilation therapy in Japan. J Neurol Neurosurg Psychiatry. 2020;91(3):285-90.

https://doi.org/10.1136/jnnp-2019-322213

PMid:31937581

Kimura F. [Tracheostomy and invasive mechanical ventilation in amyotrophic lateral sclerosis: decision-making factors and survival analysis]. Rinsho Shinkeigaku. 2016;56(4):241-7.

https://doi.org/10.5692/clinicalneurol.cn-000837

PMid:27025993

Vianello A, Concas A. Tracheostomy ventilation in ALS: a Japanese bias. J Neurol Sci. 2014;344(1):3-4.

https://doi.org/10.1016/j.jns.2014.06.050

PMid:25012483

Turner MR, Faull C, McDermott CJ, Nickol AH, Palmer J, Talbot K. Tracheostomy in motor neurone disease. Pract Neurol. 2019;19(6):467-75.

https://doi.org/10.1136/practneurol-2018-002109

PMid:31273080

Sales de Campos P, Olsen WL, Wymer JP, Smith BK. Respiratory therapies for Amyotrophic Lateral Sclerosis: A state of the art review. Chron Respir Dis. 2023;20:14799731231175915.

https://doi.org/10.1177/14799731231175915

PMid:37219417 PMCid:PMC10214054

Henschke C. Provision and financing of assistive technology devices in Germany: A bureaucratic odyssey The case of amyotrophic lateral sclerosis and Duchenne muscular dystrophy. Health policy. 2012;105(2-3):176-84.

https://doi.org/10.1016/j.healthpol.2012.01.013

PMid:22349416

Brizzi KT, Bridges JFP, Yersak J, Balas C, Thakur N, Galvin M, et al. Understanding the needs of people with ALS: a national survey of patients and caregivers. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(5-6):355-63.

https://doi.org/10.1080/21678421.2020.1760889

PMid:32396393

Olesen LK, la Cour K, With H, Mahoney AF, Handberg C. A cross-sectional evaluation of acceptability of an online palliative rehabilitation program for family caregivers of people with amyotrophic lateral sclerosis and cognitive and behavioral impairments. BMC Health Serv Res. 2022;22(1):697.

https://doi.org/10.1186/s12913-022-07986-4

PMid:35610609 PMCid:PMC9128325

Olesen LK, la Cour K, With H, Handberg C. Reflections of family caregivers and health professionals on the everyday challenges of caring for persons with amyotrophic lateral sclerosis and cognitive impairments: a qualitative study. Palliat Care Soc Pract. 2022;16:26323524221077702.

https://doi.org/10.1177/26323524221077702

PMid:35187490 PMCid:PMC8855464

de Wit J, Bakker LA, van Groenestijn AC, van den Berg LH, Schröder CD, Visser-Meily JM, et al. Caregiver burden in amyotrophic lateral sclerosis: a systematic review. Palliat Med. 2018;32(1):231-45.

https://doi.org/10.1177/0269216317709965

PMid:28671483 PMCid:PMC5784458

Miller R, Jackson C, Kasarskis E, England J, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1227-33.

https://doi.org/10.1212/WNL.0b013e3181bc01a4

PMid:19822873 PMCid:PMC2764728

Aoun SM, Connors SL, Priddis L, Breen LJ, Colyer S. Motor Neurone Disease family carers' experiences of caring, palliative care and bereavement: an exploratory qualitative study. Palliat Med. 2012;26(6):842-50.

https://doi.org/10.1177/0269216311416036

PMid:21775409

Hogden A, Foley G, Henderson RD, James N, Aoun SM. Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. J Multidiscip Healthc. 2017; 10: 205-15.

https://doi.org/10.2147/JMDH.S134992

PMid:28579792 PMCid:PMC5446964

Paganoni S, Macklin EA, Lee A, Murphy A, Chang J, Zipf A, et al. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(5-6):453-6.

https://doi.org/10.3109/21678421.2014.903974

PMid:24981792 PMCid:PMC4433003

Downloads

Published

2025-07-02

How to Cite

Behroozinia, M., & Khosrawi, S. (2025). Rehabilitation Interventions in Adults with Amyotrophic Lateral Sclerosis: A Review: Rehabilitation in Adults with ALS. Galen Medical Journal, e3708. https://doi.org/10.31661/gmj.vi.3708

Issue

Section

Review Article